<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is the second leading cause of <z:hpo ids='HP_0011420'>death</z:hpo> from <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in the United States </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">Colorectal cancers</z:e> have a prolonged latency following initiation that may span decades providing ample time for implementing a chemoprevention strategy that could block or reverse the progression to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Cdk4 pathway alterations have been linked to a number of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> including <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>In these experiments we focused on the Cdk4 pathway and its role in intestinal <z:mp ids='MP_0002006'>tumorigenesis</z:mp> as a possible target in chemoprevention strategies </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: We evaluated the effect of Cdk4 blockade on the prevention of <z:e sem="disease" ids="C0021841" disease_type="Neoplastic Process" abbrv="">intestinal tumor</z:e> formation by crossing Cdk4-/- mice to Apc-/+ mice </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, we tested the effect of the dietary compound silibinin on the Cdk4 pathway in Apc-/+ mice and HT-29 <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells in culture </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Cdk4-/- mice backcrossed to Apc-/+ mice reduced intestinal <z:mpath ids='MPATH_270'>adenoma</z:mpath> formation compared to Apc-/+ controls </plain></SENT>
<SENT sid="7" pm="."><plain>Silibinin effectively targeted the Cdk4 pathway causing hypophosphorylation of the <z:hpo ids='HP_0009919'>retinoblastoma</z:hpo> protein, inhibited cell growth, and induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>As a result silibinin blocked the development of intestinal <z:mpath ids='MPATH_270'>adenomas</z:mpath> by 52% in this genetic model (Apc-/+ mice) of early events in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> formation </plain></SENT>
<SENT sid="9" pm="."><plain>No toxic abnormalities were detected in mice which received silibinin </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Modification of the Cdk4 pathway using a natural plant-derived compound such as silibinin may be a useful chemopreventive strategy for colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
</text></document>